JAK2 and myeloproliferative disorder: The JAK2 46/1 haplotype has emerged as a significant germline genetic factor that predisposes individuals to myeloproliferative neoplasms (MPNs), particularly through its strong association with the acquisition of the JAK2 V617F somatic mutation [47,89].